CHECK Ampligen has been used in humans for years for CFS - very similar to Long Haul Covid
CHECK - Industry renown thought leader who is Director of the WHO has been working on Ampligen through Japan NIID
CHECK - Roswell and other top cancer researchers have been ramping up testing of Ampligen
CHECK - company has about $1.40 in net cash and restructured in 2016
CHECK - Neal Burnette godfather of vaccines is on Ampligens board as of 2016
CHECK - Ampligen is a TLR3 agonist which decreased viral yields in Sars and now might work as a intranasal prophylaxis
UNCHECK - valuation of co. is less than 50mm does not compute give safety history and multiple at bats in cancer covid and CFS